1. Home
  2. JMIA vs SLBT Comparison

JMIA vs SLBT Comparison

Compare JMIA & SLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jumia Technologies AG each representing two

JMIA

Jumia Technologies AG each representing two

SELL

Current Price

$6.11

Market Cap

865.9M

ML Signal

SELL

Logo SL Science Holding Limited Ordinary Shares

SLBT

SL Science Holding Limited Ordinary Shares

SELL

Current Price

$1.55

Market Cap

846.7M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
JMIA
SLBT
Founded
2012
N/A
Country
Germany
Taiwan
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
865.9M
846.7M
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
JMIA
SLBT
Price
$6.11
$1.55
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $12.13
N/A
AVG Volume (30 Days)
★ 1.2M
70.5K
Earning Date
11-11-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$26.10
N/A
Revenue Next Year
$24.21
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.59
$1.42
52 Week High
$14.72
$6.25

Technical Indicators

Market Signals
Indicator
JMIA
SLBT
Relative Strength Index (RSI) 36.83 39.30
Support Level $5.70 $1.42
Resistance Level $6.29 $1.98
Average True Range (ATR) 0.26 0.14
MACD -0.11 0.04
Stochastic Oscillator 32.78 27.72

Price Performance

Historical Comparison
JMIA
SLBT

About JMIA Jumia Technologies AG each representing two

Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace that connects sellers with consumers. The logistics services of the company enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. The company generates revenue from first-party sales, third-party sales, marketing and advertising, and the provision of other services. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.

About SLBT SL Science Holding Limited Ordinary Shares

SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

Share on Social Networks: